These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34440804)
41. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Rizzo NO; Maloney E; Pham M; Luttrell I; Wessells H; Tateya S; Daum G; Handa P; Schwartz MW; Kim F Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):758-65. PubMed ID: 20093624 [TBL] [Abstract][Full Text] [Related]
42. Adiponectin resistance and vascular dysfunction in the hyperlipidemic state. Li R; Lau WB; Ma XL Acta Pharmacol Sin; 2010 Oct; 31(10):1258-66. PubMed ID: 20802503 [TBL] [Abstract][Full Text] [Related]
43. Severe Brown Fat Lipoatrophy Aggravates Atherosclerotic Process in Male Mice. Gómez-Hernández A; Beneit N; Escribano Ó; Díaz-Castroverde S; García-Gómez G; Fernández S; Benito M Endocrinology; 2016 Sep; 157(9):3517-28. PubMed ID: 27414981 [TBL] [Abstract][Full Text] [Related]
44. Effect of endothelium-specific insulin resistance on endothelial function in vivo. Duncan ER; Crossey PA; Walker S; Anilkumar N; Poston L; Douglas G; Ezzat VA; Wheatcroft SB; Shah AM; Kearney MT Diabetes; 2008 Dec; 57(12):3307-14. PubMed ID: 18835939 [TBL] [Abstract][Full Text] [Related]
45. Impaired Insulin Signaling is Associated with Hepatic Mitochondrial Dysfunction in IR Franko A; Kunze A; Böse M; von Kleist-Retzow JC; Paulsson M; Hartmann U; Wiesner RJ Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28556799 [TBL] [Abstract][Full Text] [Related]
46. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β. Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320 [TBL] [Abstract][Full Text] [Related]
47. Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium. Li Q; Park K; Li C; Rask-Madsen C; Mima A; Qi W; Mizutani K; Huang P; King GL Circ Res; 2013 Aug; 113(4):418-27. PubMed ID: 23759514 [TBL] [Abstract][Full Text] [Related]
49. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance. Sajan MP; Standaert ML; Rivas J; Miura A; Kanoh Y; Soto J; Taniguchi CM; Kahn CR; Farese RV Diabetologia; 2009 Jun; 52(6):1197-207. PubMed ID: 19357831 [TBL] [Abstract][Full Text] [Related]
50. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913 [TBL] [Abstract][Full Text] [Related]
51. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway. Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715 [TBL] [Abstract][Full Text] [Related]
52. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Nevado C; Valverde AM; Benito M Endocrinology; 2006 Aug; 147(8):3709-18. PubMed ID: 16644916 [TBL] [Abstract][Full Text] [Related]
53. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes. Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563 [TBL] [Abstract][Full Text] [Related]